Get the Stockscreener App
69.04
2.37%
1.60
After Hours:
67.11
-1.93
-2.80%
Solventum Corp stock is traded at $69.04, with a volume of 1.94M.
It is up +2.37% in the last 24 hours and up +8.60% over the past month.
Solventum Corp is a healthcare company developing, manufacturing, and commercializing solutions leveraging material science, data science, and digital capabilities to address customer and patient needs. Its segments include MedSurg, which earns maximum revenue and provides wound therapy, I.V. site management, surgical supplies, medical tapes and wraps, stethoscopes, medical electrodes, and OEM medical technologies; Dental Solutions, offering dental and orthodontic products such as brackets, restorative cements, and bonding agents; and Health Information Systems, providing software solutions including physician documentation, coding automation, speech recognition, and data visualization platforms. It operates in the United States, which earns the majority of revenue, and internationally.
See More
Previous Close:
$67.44
Open:
$67.68
24h Volume:
1.94M
Relative Volume:
1.52
Market Cap:
$11.97B
Revenue:
$8.35B
Net Income/Loss:
$1.56B
P/E Ratio:
7.7802
EPS:
8.8738
Net Cash Flow:
$-4.00M
1W Performance:
+2.27%
1M Performance:
+8.60%
6M Performance:
+1.99%
1Y Performance:
+3.21%
1-Day Range:
$67.03
$69.19
1-Week Range:
$65.44
$69.19
52-Week Range:
$62.38
$88.20
Solventum Corp Stock (SOLV) Company Profile
Name
Solventum Corp
Sector
Industry
Phone
651-733-1110
Address
C/O 3M COMPANY, ST. PAUL
Compare SOLV vs ISRG, BDX, MDLN, ALC, RMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SOLV
Solventum Corp
|
69.04 | 11.69B | 8.35B | 1.56B | -4.00M | 8.8738 |
ISRG
Intuitive Surgical Inc
|
451.38 | 160.21B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
144.17 | 41.62B | 21.92B | 1.76B | 2.63B | 6.1223 |
MDLN
Medline Inc
|
45.32 | 37.37B | 28.43B | 1.16B | 1.26B | 1.4457 |
ALC
Alcon Inc
|
74.45 | 35.82B | 10.40B | 980.00M | 1.61B | 1.9749 |
RMD
Resmed Inc
|
207.88 | 30.38B | 5.40B | 1.49B | 1.78B | 10.12 |
Solventum Corp Stock (SOLV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-24-26 | Initiated | Rothschild & Co Redburn | Sell |
| Jan-26-26 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Jan-20-26 | Upgrade | Mizuho | Neutral → Outperform |
| Dec-02-25 | Upgrade | BTIG Research | Neutral → Buy |
| Oct-01-25 | Initiated | UBS | Neutral |
| Sep-11-25 | Initiated | Jefferies | Hold |
| Jul-15-25 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Jul-01-25 | Upgrade | Argus | Hold → Buy |
| Jun-06-25 | Initiated | KeyBanc Capital Markets | Sector Weight |
| May-19-25 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-04-24 | Initiated | Mizuho | Neutral |
| Oct-08-24 | Initiated | Stifel | Buy |
| Oct-07-24 | Initiated | Piper Sandler | Neutral |
| Sep-26-24 | Initiated | Wolfe Research | Peer Perform |
| Sep-05-24 | Initiated | BTIG Research | Neutral |
| Jun-24-24 | Initiated | Argus | Hold |
| May-30-24 | Initiated | Goldman | Sell |
| May-10-24 | Initiated | BofA Securities | Neutral |
| Apr-10-24 | Initiated | Morgan Stanley | Equal-Weight |
| Apr-08-24 | Initiated | Wells Fargo | Equal Weight |
| Apr-02-24 | Initiated | Edward Jones | Hold |
View All
Solventum Corp Stock (SOLV) Latest News
Solventum Corporation Q1 2026 Financial Results and Highlights – SEC 10-Q Filing - Minichart
Assessing Solventum (SOLV) Valuation After Recent Share Price Rebound And Product Pipeline Progress - simplywall.st
Solventum posts Q1 sales, adjusted EPS beats - MassDevice
Solventum Earnings Call Signals Margin Momentum Ahead - TipRanks
Solventum outlines EPS toward high end of $6.40-$6.60 range while expecting $100M-$120M annual tariff headwinds - MSN
Solventum forecasts annual profit at higher end on wound care demand - WHTC
Solventum Q1 FY26 slides: earnings beat amid portfolio transformation - Investing.com
Transcript : Solventum Corporation, Q1 2026 Earnings Call, May 05, 2026 - marketscreener.com
Solventum (SOLV) Tops Q1 Earnings and Revenue Estimates - Yahoo Finance
Solventum’s Wound-Care Demand Lifts Profit Outlook, Not Its Stock - Finimize
Solventum (SOLV) Reports Q1 Earnings: What Key Metrics Have to Say - Yahoo! Finance Canada
Earnings call transcript: Solventum Q1 2026 earnings beat expectations - Investing.com
Solventum Q1 2026 Earnings Call: Complete Transcript - Benzinga
Profits slide as Solventum (NYSE: SOLV) faces tariffs, restructuring and weak cash flow - Stock Titan
Solventum Corp. stock rises Tuesday, outperforms market - MarketWatch
Solventum Corporation 2026 Q1ResultsEarnings Call Presentation (NYSE:SOLV) 2026-05-05 - Seeking Alpha
Solventum Q1 Adjusted Earnings Rise, Sales Decline - marketscreener.com
Solventum : Quarterly Financial Update Q1 2026 - marketscreener.com
Solventum Corp (NYSE:SOLV) Shares Flat After Q1 Beat - ChartMill
Solventum (NYSE:SOLV) Exceeds Q1 CY2026 Expectations - Yahoo! Finance Canada
Solventum: Q1 Earnings Snapshot - marketscreener.com
Earnings Flash (SOLV) Solventum Corporation Reports Q1 Revenue $2.01B, vs. FactSet Est of $1.97B - marketscreener.com
Adjusted EPS rises as Solventum (NYSE: SOLV) keeps 2026 outlook - Stock Titan
Solventum Corporation Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Solventum earnings up next as AI concerns test turnaround story By Investing.com - Investing.com Nigeria
Solventum earnings up next as AI concerns test turnaround story - Investing.com UK
SOLV SEC FilingsSolventum Corporation 10-K, 10-Q, 8-K Forms - Stock Titan
Solventum stock is recovering: What's going on? - MSN
Solventum Corp. stock rises Monday, outperforms market - MarketWatch
Solventum to Post Q1 Earnings: Is a Beat Likely for the Stock? - Zacks Investment Research
Solventum (SOLV) Reports Q1: Everything You Need To Know Ahead Of Earnings - Yahoo Finance
Solventum gains after activist Trian sends letter urging changes (update) - MSN
Solventum (SOLV) reports Q1: Everything you need to know ahead of earnings - MSN
Health Industry Shakeup: From Solventum Overhaul to Breast Cancer Drug Approvals - Devdiscourse
US Bancorp DE Has $35.23 Million Holdings in Solventum Corporation $SOLV - MarketBeat
Trian’s Push For Cuts And Buybacks Might Change The Case For Investing In Solventum (SOLV) - simplywall.st
Solventum Corp. stock falls Friday, underperforms market - MarketWatch
Solventum (SOLV) director settles 3,403 RSUs into Common Stock - Stock Titan
[Form 4] Solventum Corp Insider Trading Activity - Stock Titan
Solventum (SOLV) director converts 3,403 RSUs to common stock, holds 8,947 shares - Stock Titan
Solventum (NYSE: SOLV) director converts 3,403 RSUs into common stock - Stock Titan
Solventum (SOLV) director converts 3,403 RSUs into common stock - Stock Titan
Director at Solventum (NYSE: SOLV) exercises 3,403 RSUs into shares - Stock Titan
Director at Solventum (SOLV) acquires 3,403 shares via RSU exercise - Stock Titan
Director at Solventum (SOLV) exercises 3,403 RSUs into stock - Stock Titan
Solventum (SOLV) director converts 4,916 RSUs into Common Stock holdings - Stock Titan
Solventum (SOLV) director Carlos Alban settles 3,403 RSUs into common stock - Stock Titan
Peltz's Trian urges Solventum to rightsize costs, divest non-core businesses - Reuters
Solventum gains on report activist Trian sends letter urging changes - MSN
Vanguard Group Inc. Reduces Holdings in Solventum Corporation $SOLV - MarketBeat
Peltz’s Trian urges Solventum to rightsize costs, divest non-core businesses - WHTC
Solventum Corp Stock (SOLV) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.44%
0.78%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):